Statistics for Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK
Total visits
| views | |
|---|---|
| Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK | 58 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| pone.0252048.pdf | 60 |
| java.util.UUID:9ed3a6c1-b54e-4d00-a734-e5fd9a08322d | 53 |
| java.util.UUID:75b2fd51-b55f-4925-9ae5-a46b692eb167 | 52 |
| java.util.UUID:c2b7817a-9b63-4f55-8e6c-2c3b03dd15bc | 12 |
Top country views
| views | |
|---|---|
| United States | 47 |
| France | 2 |
| Belgium | 1 |
| Japan | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 41 |
| Paris | 2 |
| Ann Arbor | 1 |
| Brussels | 1 |
| Houston | 1 |
| Louisville | 1 |
| Parkville | 1 |
| Seremban | 1 |